Heartbeam Inc
BEAT0.996USD
-0.024-2.39%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
33.59MCap. mercado
PérdidaP/E TTM
Más Datos de Heartbeam Inc Compañía
HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
Información de la empresa
Símbolo de cotizaciónBEAT
Nombre de la empresaHeartbeam Inc
Fecha de salida a bolsaOct 14, 2021
Director ejecutivoMr. Robert P. (Rob) Eno
Número de empleados21
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 14
Dirección2118 Walsh Ave., Suite 210
CiudadSANTA CLARA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal95050
Teléfono14088994443
Sitio Webhttps://www.heartbeam.com/
Símbolo de cotizaciónBEAT
Fecha de salida a bolsaOct 14, 2021
Director ejecutivoMr. Robert P. (Rob) Eno
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Branislav Vajdic, Ph.D.
Dr. Branislav Vajdic, Ph.D.
President, Founder, Director
President, Founder, Director
911.39K
+0.14%
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Executive Chairman of the Board and Independent Director
Executive Chairman of the Board and Independent Director
244.79K
--
Ms. Marga Ortigas-Wedekind
Ms. Marga Ortigas-Wedekind
Independent Director
Independent Director
129.12K
--
Mr. Timothy (Tim) Cruickshank
Mr. Timothy (Tim) Cruickshank
Chief Financial Officer
Chief Financial Officer
17.65K
--
Mr. Kenneth (Ken) Nelson
Mr. Kenneth (Ken) Nelson
Independent Director
Independent Director
--
--
Dr. Michael R. Jaff
Dr. Michael R. Jaff
Independent Director
Independent Director
--
--
Mr. Willem P. Elfrink
Mr. Willem P. Elfrink
Independent Director
Independent Director
--
--
Mr. Mark E. Strome
Mr. Mark E. Strome
Independent Director
Independent Director
--
--
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President - MZ North America
Executive Vice President - MZ North America
--
--
Mr. Robert P. (Rob) Eno
Mr. Robert P. (Rob) Eno
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Branislav Vajdic, Ph.D.
Dr. Branislav Vajdic, Ph.D.
President, Founder, Director
President, Founder, Director
911.39K
+0.14%
Mr. Richard M. (Rich) Ferrari
Mr. Richard M. (Rich) Ferrari
Executive Chairman of the Board and Independent Director
Executive Chairman of the Board and Independent Director
244.79K
--
Ms. Marga Ortigas-Wedekind
Ms. Marga Ortigas-Wedekind
Independent Director
Independent Director
129.12K
--
Mr. Timothy (Tim) Cruickshank
Mr. Timothy (Tim) Cruickshank
Chief Financial Officer
Chief Financial Officer
17.65K
--
Mr. Kenneth (Ken) Nelson
Mr. Kenneth (Ken) Nelson
Independent Director
Independent Director
--
--
Dr. Michael R. Jaff
Dr. Michael R. Jaff
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Strome Mezzanine Fund, L.P.
9.32%
Schwartzberg (Andrew)
5.62%
Public Ventures LLC
3.15%
Vajdic (Branislav)
2.70%
The Vanguard Group, Inc.
2.43%
Other
76.78%
Accionistas
Accionistas
Proporción
Strome Mezzanine Fund, L.P.
9.32%
Schwartzberg (Andrew)
5.62%
Public Ventures LLC
3.15%
Vajdic (Branislav)
2.70%
The Vanguard Group, Inc.
2.43%
Other
76.78%
Tipos de accionistas
Accionistas
Proporción
Corporation
12.47%
Individual Investor
11.68%
Investment Advisor
7.43%
Investment Advisor/Hedge Fund
1.57%
Research Firm
0.04%
Other
66.82%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
72
11.33M
33.52%
+116.07K
2025Q1
73
11.32M
33.47%
+184.21K
2024Q4
67
10.34M
30.80%
-62.00K
2024Q3
67
10.57M
36.60%
-314.36K
2024Q2
63
10.32M
35.80%
-451.58K
2024Q1
59
9.95M
34.92%
-469.47K
2023Q4
60
9.79M
39.69%
+2.93M
2023Q3
56
9.76M
43.96%
+2.51M
2023Q2
53
8.43M
39.17%
+5.45M
2023Q1
36
2.26M
27.56%
-577.08K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Strome Mezzanine Fund, L.P.
3.15M
9.32%
--
--
Mar 31, 2025
Schwartzberg (Andrew)
1.90M
5.62%
--
--
Mar 31, 2025
Public Ventures LLC
1.07M
3.15%
+3.91K
+0.37%
Mar 31, 2025
Vajdic (Branislav)
911.39K
2.7%
+1.29K
+0.14%
Mar 31, 2025
The Vanguard Group, Inc.
823.01K
2.43%
+59.31K
+7.77%
Mar 31, 2025
Elfrink (Willhem P.)
424.81K
1.26%
--
--
Mar 31, 2025
Smith, Salley & Associates, LLC
367.65K
1.09%
+117.65K
+47.06%
Mar 31, 2025
Geode Capital Management, L.L.C.
247.37K
0.73%
+5.53K
+2.29%
Mar 31, 2025
Ferrari (Richard M)
244.79K
0.72%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
203.04K
0.6%
+43.03K
+26.90%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
